Personalized medicine has become a popular buzz word in the healthcare field, but researchers at ASU and IBM are hoping to make things a lot more personal. They’re working on a handheld device that could read a patient’s DNA from a very small amount of blood, spit or other fluid.
Stuart Lindsay is a Physics Professor at ASU and Director of the Biodesign Institute’s Center for Single Molecule Biophysics.
As we get more access to our own genetic make-ups, there are ethical and moral issues that pop up. To talk about some of them, we turn to Art Caplan, who heads up the Division of Medical Ethics at the New York University Langone Medical Center. He likes what Lindsay and others are working on.
Art Caplan heads the Division of Medical Ethics at the NYU Langone Medical Center.
